Compare Borosil Scienti. with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 4.53%
- The company has been able to generate a Return on Equity (avg) of 4.53% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of 9.80% and Operating profit at 2.86% over the last 5 years
Negative results in Sep 25
With ROE of 4.5, it has a Expensive valuation with a 2.5 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0.04% of the company
Below par performance in long term as well as near term
Stock DNA
Industrial Products
INR 978 Cr (Small Cap)
55.00
51
0.00%
-0.27
4.53%
2.32
Total Returns (Price + Dividend) 
Borosil Scienti. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Borosil Scientific Ltd is Rated Strong Sell
Borosil Scientific Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Borosil Scientific Ltd Valuation Shifts Signal Price Attractiveness Concerns
Borosil Scientific Ltd has witnessed a marked shift in its valuation parameters, moving from fair to expensive territory, as reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite a recent uptick in share price, the company’s multiples now stand significantly above historical averages and peer benchmarks, raising questions about price attractiveness amid subdued return metrics and a challenging market backdrop.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2026 | Source : BSECertificate for the quarter ended December 31 2025
Closure of Trading Window
22-Dec-2025 | Source : BSEClosure of Trading Window
Announcement under Regulation 30 (LODR)-Credit Rating
11-Dec-2025 | Source : BSEUpdate on Credit Rating is Enclosed
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 18 FIIs (0.07%)
Kiran Kheruka (25.52%)
Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account (2.2%)
23.06%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 11.38% vs -25.87% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 169.47% vs -147.98% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024
Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 10.51% vs 9.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 11.32% vs 3.25% in Mar 2024







